Back
Sarepta Therapeutics Stock Predictions
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the corner
Sell
48
SRPT
Sarepta Therapeutics
Last Price:
131.89
Seasonality Move:
14.17%
7 Day Trial
ALL ACCESS PASS
$
7
Will Crypto Make People Rich Again Starting April 2024?
Details on how to profit here.Sarepta Therapeutics Stock Forecast
- Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 33.1% based on the past 26 years of stock performance.
- Sarepta Therapeutics has risen higher in 13 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Sarepta Therapeutics Stock Undervalued?
The current Sarepta Therapeutics [SRPT] share price is $131.82. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal. - SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Sarepta Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 33.1% based on the past 26 years of stock performance.
Sarepta Therapeutics Stock Rating
Sell
48
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics overpriced?
- Sarepta Therapeutics has risen higher in 13 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Sarepta Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sarepta.com
52-Week Data
52-Week High:
159.89
52-Week Low:
55.25
Prediction Charts
Market Cap:
12.46B
Price in USD:
131.82
Volume:
735.54K
Beta:
1.06
Technical Analysis
SMA50:
125.49
SMA100:
121.04
SMA200:
112.87
52-Wk Change:
8.7%
Stock Predictions
-
Is Sarepta Therapeutics stock public?
Yes, Sarepta Therapeutics is a publicly traded company. -
What is the Sarepta Therapeutics stock quote today?
The Sarepta Therapeutics stock price is 131.82 USD today. -
How to buy Sarepta Therapeutics stock online?
You can buy Sarepta Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-23 | 117.50 | 117.06 | 119.91 | 117.06 |
| Apr-24 | 117.66 | 124.25 | 125.13 | 117.21 |
| Apr-25 | 123.00 | 127.39 | 130.61 | 121.80 |
| Apr-26 | 127.53 | 128.77 | 131.46 | 125.62 |
| Apr-29 | 129.02 | 128.80 | 131.80 | 127.47 |
| Apr-30 | 128.65 | 126.56 | 129.70 | 126.53 |
| May-1 | 127.06 | 130.77 | 131.61 | 127.00 |
| May-2 | 140.00 | 130.58 | 142.79 | 130.05 |
| May-3 | 132.55 | 133.66 | 134.47 | 131.16 |
| May-6 | 133.60 | 135.04 | 135.16 | 132.62 |
| May-7 | 135.10 | 136.11 | 146.68 | 132.30 |
| May-8 | 137.14 | 132.58 | 137.14 | 129.45 |
| May-9 | 133.22 | 132.30 | 133.39 | 129.49 |
| May-10 | 132.87 | 131.82 | 132.87 | 129.44 |
Sarepta Therapeutics Earnings
Sarepta Therapeutics Earnings Report: Per Share Sarepta Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Sarepta Therapeutics Forecast Revenue Growth
Sarepta Therapeutics Stock Analysis: Historical quarterly revenues per share for Sarepta Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $1.85 per share, an increase next quarter of $1.52 per share, an increase this year of $5.62 per share, and an increase next year of $6.11 per share.
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.